10
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Articular Cartilage: Cause or Victim in Arthritis

Pages 31-37 | Published online: 12 Jul 2009

References

  • Jasin HE. Autoantibody specificities of immune com-plexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1985; 28:241–8.
  • Mannik M, Person RE. IgG and serum albumin isolated from cartilage of patients with RA or OA contain covalent heteropolymers with proteoglycans. Rheumatol Int 1993; 13:121–9.
  • Van den Berg WB, Lens JW, Van de Putte LBA, Van Beusekom HJ. Antigen induced arthritis: antigen han-dling and chronicity of joint inflammation. Agents Ac-tions 1982; (Suppl 11):233–41.
  • Lens JW, Van den Berg WB, Van de Putte LBA. Flare-up of antigen-induced arthritis in mice after challenge with intravenous antigen. Studies on the characteristics of and mechanisms involved in the reaction. Clin Exp Immunol 1984; 55:287–94.
  • Van den Berg WB, Van de Putte LBA, Zwarts WA, Joosten LAB. Electrical charge of the antigen determines intraarticular antigen handling and chronicity of arthritis in mice. .1 Clin Invest 1984; 74:1850–9.
  • Van den Berg WB, Van de Putte LBA. Electrical charge of the antigen determines its localization in the mouse knee joint: deep penetration of cationic BSA in hyaline articular cartilage. Am J Pathol 1985; 121:224–34.
  • Van Lent PLEM, Van den Berg WB, Schalkwijk J, Van de Putte LBA, Van den Bersselaar L. The impact of protein size and charge on its retention in articular cartilage. J Rheumatol 1987; 14:798–805.
  • Van Lent PLEM, Van den Bersselaar L, Grutters GJF, Van den Berg WB. Fate of antigen, after intravenous and intra-articular injection into mice. Role of molecular weight and charge. J Rheumatol 1989; 16:1295–303.
  • Van Lent PLEM, Dekker C, Mosterd J, Van den Bersse-laar L, Van den Berg WB. Allergic arthritis induced by cationic proteins: role of molecular weight. Immunology 1989; 67:447–52.
  • Mertz AKH, Batsford SR, Curschellas E, Kist MJ, Gon-dolf KB. Cationic Yersinia Antigen induced chronic aller-gic arthritis in rats. J Clin Invest 1991; 87:632–42.
  • Probst P, Hermann E. Meyer zum Buschenfelde KH, Fleischer B. Identification of the Yersinia subunit as a tar-get antigen for human synovial T lymphocytes in reactive arthritis. Infect Immun 1993; 61:4507–9.
  • Mikecz K, Giant TT, Buzas E, Poole AR. Proteoglycan in-duced polyarthritis and spondylitis adoptively transferred to naive BALB/c mice. Arthritis Rheum 1990; 33:866–76.
  • Cooper WA, Fava RA, Gates CA, Cremer MA, Townes AS. Acceleration of onset of CIA by intraarticular in-jection of TNF or TGF/3. Clin Exp Immunol 1992; 89:244–50.
  • Van den Berg WB, Joosten LAB, Helsen MMA, Van de Loo AAJ. Amelioration of established murine collagen induced arthritis with anti-IL-1 treatment. Clin Exp Im-munol 1994; 95:237–43.
  • Joosten LAB, Helsen MA, Van den Berg WB. Acceler-ated onset of collagen induced arthritis by remote inflam-mation. Clin Exp Immunol, in press.
  • Santambrogio L, Hochwald GM, Leu CH, Thorbecke GJ. Antagonistic effects of endogenous and exogenous TGF/3 and TNF on autoimmune disease in mice. Immunophar-macol Immunotoxicol 1993; 15:461–78.
  • Van Eden W. T cell regulation in autoimmune arthritis: possibilities for immunological intervention. Immunol Res 1990; 9:157–63.
  • Van den Berg WB, Van den Broek MF, Van de Putte LBA, Van Bruggen MCJ, Van Lent PLEM. Experimental arthritis: Importance of T cells and antigen mimicry in chronicity and treatment. In: Kresina TF, ed. Monoclonal antibodies, cytokines, and arthritis. New York, Dekker 1991; 237–52.
  • Van de Langerijt AGM, Kingston AE, Van Lent PLEM, Billingham ME, Van den Berg WB. Crossreactivity to proteoglycans in bacterial arthritis; in vivo role in disease development? Immunol Immunopathol, in press.
  • Van de Langerijt AGM, Volsen SG, Hicks CA, Craig PJ, Billingham MEJ, Van den Berg WB. Cell migration studies in the adoptive transfer of adjuvant arthritis in the Lewis rat. Immunol 1994; 81:414–9.
  • Kleinau S. Klareskog L. Oil induced arthritis in DA rats. Passive transfer by T cells but not with serum. J Autoimm 1993; 6:449–58.
  • Kingston AE, Carney SL, Hicks CA, Billingham MEJ. In vitro and in vivo effects of proteoglycan fractions in adju-vant treated rats. Agents Actions 1993; (Suppl 39):75–9.
  • Trentham DE, Dynesius-Trentham RA, Orav EJ, Corn-bitchi D, Loenzo C, Sewell KL, Hafler DA, Weiner HL. Effects of oral administration of type ll collagen on rheumatoid Arthritis. Science 1993; 261:1727–30.
  • Miller A, Al-Sabbagh A, Santos LMB, Prabhu Das MP, Weiner HL. Epitopes of myeline basic protein that trig-ger TGF release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven by-stander suppression. J Immunol 1993; 151:7307–15.
  • Alvaro-Garcia JM, Zvaifler NJ, Brown CB, Kaushansky K, Firestein GS. Cytokines in chronic inflammatory arthri-tis. J Immunol 1991; 146:3365–71.
  • Van de Loo AAJ, Van den Berg WE. Effects of murine re-combinant IL-1 on synovial joints in mice: Measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 1990; 49:238–45.
  • Van den Berg WB, Van de Loo AAJ, Van Lent PLEM, Joosten LAB. Mechanisms of cartilage destruction in joint inflammation. Agents Actions Suppl 1993; 39:49–60.
  • Van den Berg 'WB, Van de Loo AAJ, Otterness I, Arntz OJ, Joosten LAB. In vivo evidence for a key role of IL-1 in cartilage destruction in experimental arthritis. In: Parnham MJ, Bray MA, Van den Berg WB, eds. Drugs in inflammation. Agents Actions 1991; (Suppl 32):159–63.
  • Van de Loo AAJ, Arntz OJ, Otterness IG, Van den Berg WB. Protection against cartilage proteoglycan synthesis inhibition by anti-interleukin 1 antibodies in experimental arthritis. J Rheumatol 1992; 19:348–56.
  • Van Lent PLEM, Van den Hoek AEM, Van den Bersselaar LAM, Van de Loo FAJ, Eykholt HE, Brouwer WFM, et al. Early cartilage degradation in cationic immune complex arthritis in mice: relative role of interleukin 1, the polymorphonuclear cell (PMN) and PMN elastase. J Rheumatol 1994; 21:321–9.
  • Van Beuningen HM, Van der Kraan PM, Arntz 0J, Van den Berg WB. Protection from interleukin 1 induced de-struction of articular cartilage by transforming growth fac-tor /3: studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis 1993; 52:185–91.
  • Beuningen HM, Van der Kraan PM, Arntz OJ, Van den Berg WB. Transforming growth factor-in stimulates artic-ular chondrocyte proteoglycan synthesis and induces os-teophyte formation in the murine knee joint. Lab Invest, in press.
  • Van den Berg WB, Van Osch GJVM, Van der Kraan PM, Van Beuningen HM. Cartilage destruction and osteophytes in instability-induced murine osteoarthritis: role of TGF/3 in osteophyte formation? Agents Actions 1993; 40:215–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.